Cross-sectional Study of the Prevalence and Risk Factors of Asymptomatic Bacteriuria in Pregnancy

NCT07001579 | Completed

• 1 other identifier: SBH-AUTI-2022-01
• Study Type: observational
• Target: 390
• Locations: 1 country
• Sites: 1

Brief Summary

Asymptomatic bacteriuria (ASB) is the presence of bacteria in the urine without symptoms of urinary tract infection. It is common during pregnancy and, if left untreated, may lead to complications such as pyelonephritis, preterm labor, and low birth weight. This cross-sectional study aims to determine the prevalence and identify associated risk factors of ASB among pregnant women attending antenatal care at a tertiary care hospital. Pregnant women meeting the inclusion criteria will be enrolled and evaluated through urine analysis and relevant history-taking. The findings may help guide future screening and treatment policies in antenatal care settings

Conditions

Urinary Tract Infection (Diagnosis); Pregnancy

Outcome Measures

Primary Outcomes (1)

• Prevalence of Asymptomatic Bacteriuria in Pregnant Women

  The proportion of pregnant women attending antenatal care who test positive for asymptomatic bacteriuria based on urine culture

  Data was collected for 6 months after approval from IRC from April 2022 to September 2022 during each participant's first antenatal care (ANC) visit irrespective of the gestational age, using simple convenient sampling method.

Eligibility Criteria

• Age: 18 Years+
• Gender Eligibility Details: Since, it is study of Asymptomatic Urinary Tract Infection in pregnancy. This involves only female.
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Pregnant women visiting the Department of Obstetrics and Gynecology OPD, (Shree Birendra Hospital) located in Kathmandu for Antenatal Check-up.

You may qualify if:

• Pregnant women attending her regular ANC check-ups at the hospital.
• Who give consent to participate in the study.

You may not qualify if:

• Individuals not willing to participate
• Pregnant women showing signs and symptoms of UTI.
• Pregnant women on antibiotics or had been on antibiotics at least two weeks prior to presentation.
• Pregnant women with known underlying renal pathology.
• Pregnant women who are using immune-suppressants.

Sponsors & Collaborators

• Nepalese Army Institute of Health Sciences: lead

Study Sites (1)

Shree Birendra Hospita

Kathmandu, Bagmati, 44600, Nepal

Location

MeSH Terms

Conditions

Urinary Tract Infections; Disease

Condition Hierarchy (Ancestors)

Infections; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Dr.

Study Record Dates

• First Submitted: May 7, 2025
• First Posted: June 3, 2025
• Study Start: April 1, 2022
• Primary Completion: March 14, 2023
• Study Completion: August 26, 2024
• Last Updated: June 3, 2025

Record last verified: 2025-06

Data Sharing

• IPD Sharing: Will not share

Locations

NE (1)